BioXcel Therapeutics BTAIQ
Armistice Capital reports a 9.99% stake in BioXcel Therapeutics
- Form
- Schedule 13G
- Filed
- Importance
- Routine
- Accession
- 0001172661-25-001280
- Document
- Schedule 13G
Not explained yet; the original is on EDGAR.
Ownership stake disclosure
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Phio Pharmaceuticals PHIO public float $11M, Jun 30, 2025
- Palisade Bio PALI public float $11M, Jun 30, 2025
- Citius Pharmaceuticals CTXR public float $11M, Mar 31, 2025, over 18 months old
- Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
- Cocrystal Pharma COCP public float $12M, Jun 30, 2025
